Resultados de la búsqueda 111-120 of 13105 for Otitis externa

  1. Cirugía - Ensayos clínicos - Mayo Clinic

    The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic ...

  2. Cirugía - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to assess the differences in microvascular anastomosis outcomes between the experiment aneurysmal subarachnoid ...

  3. Médicos y departamentos

    Loscalzo J, et al., eds. Staphylococcal infections. In: Harrison's Principles of Internal Medicine. 21st ed.

  4. Médicos y departamentos

    Nici L, et al. Pharmacologic management of chronic obstructive pulmonary disease: An official American Thoracic Society clinical practice guideline. American ...

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess the differences in microvascular anastomosis outcomes between the experiment aneurysmal subarachnoid hemorrhage (aSAH)- ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate the safety and feasibility of surgical resection for pre-recurrent brain tumors. Eligible patients with surgically ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    By evaluating 30 patients undergoing robotic mitral annuloplasty, this study aims to establish the feasibility of further prospective evaluation of CT and MRI ...

  9. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...